Vitiligo

 

Below is a list of our vitiligo studies that are currently enrolling.

Daily Topical Rapamycin Therapy for the Treatment of Vitiligo (Non-Segmental Type)

  • Population: Patients aged 12 years and older
  • Study Condition: Non-segmental vitiligo
  • Study Design: This is a research study to learn whether topical rapamycin is safe and effective in patients with non-segmental type vitiligo when applied topically once daily. The study duration is 9 months. At the enrollment visit and during follow up visits, participants will have photos of the lesion(s) taken and complete questionnaires regarding quality of life and side effects experienced.
  • There will be a total of $50 compensation to participants paid in $10 installments over the course of 5 visits
    • Compensation will be provided

     

    Please contact Courtney Linkous for more information regarding ongoing vitiligo studies

  • Email: linkousc@musc.edu